Authors
Noura Mohammed Bakr, Abeer Abdel Maksoud, Nehad Abdelmawgoud Ahmad
Published in
BMC oral health. Volume 26. Issue 1. Oct 07, 2026. Epub Oct 07, 2026.
Abstract
Chemotherapy primarily treats cancer by using drugs to kill cancer cells. Curcumin, a natural adjuvant, shows promise in preventing side effects.
This study seeks to determine curcumin's protective effect against cyclophosphamide toxicity.
Twenty-one male albino rats were used in this study, divided into three groups of seven. Group I received daily oral saline. Group II was given a single dose of CP (200 mg/kg) after seven days of saline with 0.5% CMC. Group III received CP (200 mg/kg) on day seven following seven days of CUR (30 mg/kg/day). At the experiment's conclusion, the rats were euthanized under anesthesia, and their parotid salivary glands were collected.
The control group showed normal architecture. In group II, histological changes included necrosis of serous acini, striated duct, and atrophy of some acini cells. Group III displayed slight improvement in cell architecture. Cytochrome.
The study examined Curcumin's role in preventing Cyclophosphamide-induced changes.
PMID:
42892685
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0